Intestinal Perforation after Bevacizumab Treatment in Metastatic Colon Cancer: A Rare Case

Authors : Durmuş Çetin, Ebubekir Gündeş, Ulaş Aday, Hüseyin Çiyiltepe, Kamuran Değer, Mustafa Duman

Pages : 0-0

Doi:10.5798/diclemedj.0921.2016.01.0661

View : 16 | Download : 6

Publication Date : 2016-03-01

Article Type : Research Paper

Abstract :Bevacizumab is a monoclonal antibody which is targeting to vascular endothelial growth factor. It has been shown to be a promising drug on metastatic colorectal cancer and is combined with chemotherapeutic agents. One should be aware of serious complications even though bevacizumab is a well-tolerated drug. There are a few intestinal perforation cases that have been reported in the oncologic surgery literature related to the bevacizumab treatment. In this case report, we aimed to represent a 45 years old man who was diagnosed with intestinal perforation after bevacizumab treatment ten months after a metastatic colon cancer surgery. Key words: Bevacizumab, intestinal perforation, metastatic colorectal cancer
Keywords : Bevacizumab, ince barsak perforasyonu, metastatik kolorektal kanser